deltatrials
Completed PHASE1 INTERVENTIONAL 2-arm NCT02722538

Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder Cancer

A Phase 1b, Multicenter, Open Label Study Evaluating Safety, Tolerability and Preliminary Efficacy of GemRIS 225 mg in Subjects With Muscle-Invasive Transitional Cell Carcinoma of the Bladder

Sponsor: Taris Biomedical LLC

Conditions Urinary Bladder Cancer
Interventions Gemcitabine-Releasing Intravesical System (GemRIS)/TAR-200
Updated 11 times since 2017 Last updated: Sep 15, 2023 Started: May 31, 2016 Primary completion: May 2, 2019 Completion: May 2, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02722538, this PHASE1 trial focuses on Urinary Bladder Cancer and remains completed. Sponsored by Taris Biomedical LLC, it has been updated 11 times since 2016, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~May 2017 · 3 months · monthly snapshotRecruiting~May 2017 – ~Mar 2018 · 10 months · monthly snapshotRecruiting~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotRecruiting~Jun 2018 – ~Sep 2019 · 15 months · monthly snapshotRecruiting~Sep 2019 – ~Feb 2020 · 5 months · monthly snapshotActive Not Recruiting~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotCompleted~Jan 2021 – ~Oct 2023 · 33 months · monthly snapshotCompleted~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Oct 2023 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jan 2021 — Oct 2023 [monthly]

    Completed PHASE1

  5. Feb 2020 — Jan 2021 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

▶ Show 6 earlier versions

  1. Sep 2019 — Feb 2020 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  2. Jun 2018 — Sep 2019 [monthly]

    Recruiting PHASE1

  3. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE1

  4. May 2017 — Mar 2018 [monthly]

    Recruiting PHASE1

  5. Feb 2017 — May 2017 [monthly]

    Recruiting PHASE1

  6. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1

    First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Taris Biomedical LLC
Data source: Taris Biomedical LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations